Clinical Laserthermia Systems AB (publ) announced that Katarina Lundqvist assumes the role as Interim CFO as of 18 September, taking over from Rolf Ho Bornschein who resigned earlier in September. Katarina Lundqvist has extensive experience from finance director roles in international, pharmaceutical and medtech companies. Katarina Lundqvist assumes the role as Interim CFO as of 18 September 2023.

As announced on 8 September, Rolf Ho Bornschein has decided to leave his role as CFO at CLS. He will remain with the company during his notice period, or no longer than to 25 November, and he will meanwhile assist the company during the transition period. Katarina Lundqvist, who currently is a Financial Consultant at MPYA Finance, has previously held senior positions at life science companies active in global markets.

Most recently she was Nordic Finance Director at Ferring Pharmaceuticals, and before that Finance Manager at Jolife, owned by the American medtech company Stryker. Katarina has also been Finance Manager at Tunstall, and CFO at Setterwalls Advokatbyrå, a law firm in Malmö, Sweden.